Wróbel, K.; Wołowiec, S.; Markowicz, J.; Wałajtys-Rode, E.; Uram, Ł.
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines. Cancers 2022, 14, 714.
https://doi.org/10.3390/cancers14030714
AMA Style
Wróbel K, Wołowiec S, Markowicz J, Wałajtys-Rode E, Uram Ł.
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines. Cancers. 2022; 14(3):714.
https://doi.org/10.3390/cancers14030714
Chicago/Turabian Style
Wróbel, Konrad, Stanisław Wołowiec, Joanna Markowicz, Elżbieta Wałajtys-Rode, and Łukasz Uram.
2022. "Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines" Cancers 14, no. 3: 714.
https://doi.org/10.3390/cancers14030714
APA Style
Wróbel, K., Wołowiec, S., Markowicz, J., Wałajtys-Rode, E., & Uram, Ł.
(2022). Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines. Cancers, 14(3), 714.
https://doi.org/10.3390/cancers14030714